REGENXBIO, Inc. (RGNX)
9.49
+0.30
(+3.26%)
USD |
NASDAQ |
Apr 17, 16:00
9.40
-0.09
(-0.95%)
After-Hours: 06:57
REGENXBIO SG&A Expense (Quarterly) : 22.38M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 128.30M |
| AbbVie, Inc. | 3.895B |
| Replimune Group, Inc. | 18.73M |
| Ocugen, Inc. | 6.132M |
| Krystal Biotech, Inc. | 41.45M |